Table 4. Characteristics of patients... | American Society of Hematology

Table 4.

Characteristics of patients with B-cell malignancies experiencing tumor reduction

Patient	Diagnosis	No. of prior therapies	Therapy duration, d	Baseline SPD, cm²	Nadir SPD, cm²	Change SPD, %
1	FL	2	126	49.8	25.4	−49%
2	DLBCL	3	110	14.5	10.5	−28%
3	CLL	5	155	74.5	69.5	−7%
4	MZL	4	154	28.4	27.2	−4%

Patient	Diagnosis	No. of prior therapies	Therapy duration, d	Baseline SPD, cm²	Nadir SPD, cm²	Change SPD, %
1	FL	2	126	49.8	25.4	−49%
2	DLBCL	3	110	14.5	10.5	−28%
3	CLL	5	155	74.5	69.5	−7%
4	MZL	4	154	28.4	27.2	−4%

SPD, sum perpendicular diameters.